Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Jul 29, 2019

SELL
$166.7 - $195.41 $12.6 Million - $14.8 Million
-75,700 Closed
0 $0
Q1 2019

Apr 26, 2019

BUY
$180.87 - $203.88 $13.7 Million - $15.4 Million
75,700 New
75,700 $14.4 Million
Q1 2018

Apr 27, 2018

SELL
$169.43 - $198.0 $19.2 Million - $22.4 Million
-113,300 Closed
0 $0
Q3 2017

Oct 30, 2017

BUY
$167.29 - $191.0 $19 Million - $21.6 Million
113,300
113,300 $21.1 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Adams Diversified Equity Fund, Inc. Portfolio

Follow Adams Diversified Equity Fund, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adams Diversified Equity Fund, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Adams Diversified Equity Fund, Inc. with notifications on news.